Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
-1.2000 (-96.77%)
Jun 12, 2025, 8:00 PM EDT
Hemogenyx Pharmaceuticals Employees
Hemogenyx Pharmaceuticals had 16 employees as of December 31, 2024. The number of employees decreased by 1 or -5.88% compared to the previous year.
Employees
16
Change (1Y)
-1
Growth (1Y)
-5.88%
Revenue / Employee
n/a
Profits / Employee
-$439,675
Market Cap
10.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Hemogenyx Pharmaceuticals News
- 2 days ago - Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion - Accesswire
- 15 days ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 16 days ago - Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests - Accesswire
- 5 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol - Accesswire
- 6 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 6 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy - Accesswire
- 7 weeks ago - Hemogenyx Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report - Accesswire